Molecular-Targeted Therapy for Duchenne Muscular Dystrophy: Progress and Potential

Author： Scimè Anthony   Rudnicki Michael A.  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.12, Iss.2, 2008-01, pp. : 99-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Scoliosis in Duchenne Muscular Dystrophy

By  

Respiration, Vol. 66, Iss. 5, 1999-09 ,pp. : 463-463

Karger

Access to resources Recommend Favorite

By  

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 8, 2015-08 ,pp. : 759-764

John Wiley & Sons Inc

Access to resources Recommend Favorite

Co‐administration of deflazacort and doxycycline: a potential pharmacotherapy for Duchenne muscular dystrophy

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 7, 2015-07 ,pp. : 788-794

John Wiley & Sons Inc

Access to resources Recommend Favorite

DISABILITIES IN CHILDREN WITH DUCHENNE MUSCULAR DYSTROPHY: A PROFILE

By Nair K. P. Sivaraman   Vasanth Anisya   Gourie-Devi M   Taly Arun B.   Rao S   Gayathri N   Murali T  

Journal of Rehabilitation Medicine, Vol. 33, Iss. 4, 2001-07 ,pp. : 147-149

Medical Journals Limited

Access to resources Recommend Favorite

Upper limb function in adults with Duchenne muscular dystrophy

By Bartels Bart   Pangalila Robert F.   Bergen Michael P.   Cobben Nicolle A. M.   Stam Henk J.   Roebroeck Marij E.  

Journal of Rehabilitation Medicine, Vol. 43, Iss. 9, 2011-09 ,pp. : 770-775

Medical Journals Limited

Access to resources Recommend Favorite